Covaxin found to neutralise 617 variant of COVID-19: America’s top pandemic expert Dr Fauci

  • by
Developed by Bharat Biotech in partnership with National Institute of Virology and the Indian Council of Medical Research, Covaxin was approved for emergency use on January 3. Trial results later showed the vaccine has an efficacy of 78 per cent.